Shocking Resignation: Top FDA Vaccine Official Steps Down Over Kennedy’s ‘Dangerous Misinformation’
Dr. Peter Marks, the lead official overseeing vaccines at the Food and Drug Administration (FDA), has stepped down following a contentious clash with Health Secretary Robert F. Kennedy Jr. In a fiery resignation letter, Dr. Marks accused Mr. Kennedy of prioritizing misinformation and compromising public health, stating, “Truth and transparency are not desired by the secretary, but instead, he seeks subservient confirmation of his misinformation and lies.”
The unexpected resignation comes amid escalating tensions as Mr. Kennedy continues to make controversial claims about vaccines. Recently, he suggested that Covid-19 does not impact healthy individuals, a stance conflicting with studies indicating that around 30% of early pandemic fatalities involved people without underlying health conditions. Furthermore, Mr. Kennedy has advocated for vitamin A during a significant measles outbreak in Texas, minimizing established vaccine efficacy.
Dr. Marks, a pivotal figure during the coronavirus pandemic, was informed by the Department of Health and Human Services that he faced termination unless he resigned. Striving to combat misinformation, Dr. Marks urged open dialogue with the National Academies of Sciences, Engineering, and Medicine to address vaccine safety and transparency concerns, but these efforts were rebuffed.
In his resignation letter, Dr. Marks warned against undermining public confidence in vaccines, which have met the FDA’s rigorous standards for quality and safety over decades. He highlighted the dire consequences of misinformation by referencing the deaths of over 100,000 unvaccinated children in Africa and Asia due to measles, a disease previously eradicated in the U.S.
Adding his voice to the conversation, Dr. Peter Hotez from Baylor University lauded Dr. Marks for his extraordinary dedication, lamenting his departure. Dr. Peter Lurie, a former FDA associate commissioner, emphasized the critical importance of maintaining scientific integrity, expressing concern over the secretary’s apparent disregard for science-based evidence.
Despite Mr. Kennedy’s assurances during his Senate confirmation hearings to uphold vaccinations’ importance, his actions have sown doubt about vaccine safety. He announced the creation of a new office focusing on vaccine injuries, a move critiqued by experts like Dr. Michael Osterholm of the University of Minnesota for potentially exaggerating the perceived risk of vaccines.
Andrew Nixon, a spokesperson for the Department of Health and Human Services, issued a statement regarding Dr. Marks’ exit, stating, “If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy.”
Dr. Marks steered the FDA during pivotal moments, including the Operation Warp Speed era, which expedited vaccine development under the Trump administration. He repeatedly highlighted the need to consider the threat of Covid-19 to young children, underscoring the importance of vaccinations for those under five.
This development signals a potentially challenging period for the FDA as it navigates the complexities of vaccine policy amidst a backdrop of increasing vaccine skepticism and misinformation. The agency’s future will depend on its ability to uphold scientific standards while addressing public concerns effectively.
Original Source: https://www.nytimes.com/2025/03/28/health/fda-vaccines-rfk-jr-peter-marks.html
Category : Ethics and Official Misconduct,Vaccination and Immunization,Medicine and Health,Appointments and Executive Changes,Rumors and Misinformation,Measles,Coronavirus (2019-nCoV),Food and Drug Administration,Marks, Peter W,Trump, Donald J
Tags:
Publish Date: 2025-03-29 07:11:00
